Sublobar resections—current evidence and future challenges

Several factors have contributed to a heightened interest in the oncologic efficacy of sublobar resections versus lobectomies for patients with non-small cell lung cancer (NSCLC). Firstly, the increased detection of early-stage disease in targeted screening programs has identified a growing number of patients with smaller tumours, which are more amenable to sublobar resections compared to tumours of higher clinical stage (1).